Yingying Yu

Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer

Yingying Yu, Siyu Wang, Nan Su et al. · Frontiers in Oncology · 2022 · 43 citations · Full text

Life Sciences, Immunology, Oncology +17

Efficacy and safety of sintilimab in combination with chemotherapy in previously untreated advanced or metastatic nonsquamous or squamous NSCLC: two cohorts of an open-label, phase 1b study

Haiping Jiang, Yulong Zheng, Jiong Qian et al. · Cancer Immunology Immunotherapy · 2020 · 31 citations · Full text

Medicine, Oncology, Pharmacology +17

Integrated Serum Pharmacochemistry and Network Pharmacology Approach to Explore the Effective Components and Potential Mechanisms of Menispermi Rhizoma Against Myocardial Ischemia

Jinxia Wei, Yingying Yu, Yue Zhang et al. · Frontiers in Chemistry · 2022 · 23 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational Therapy

Shida Pan, Yingying Yu, Siyu Wang et al. · Frontiers in Immunology · 2022 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17

Deep Sequencing of T-Cell Receptors for Monitoring Peripheral CD8+ T Cells in Chinese Advanced Non–Small-Cell Lung Cancer Patients Treated With the Anti–PD-L1 Antibody

Sheng Jin, Huadi Wang, Xiao Liu et al. · Frontiers in Molecular Biosciences · 2021 · 20 citations · Full text

Medicine, Immunology, Oncology +17